Thiogenesis Announces Addition of Dr. Vince Stanton Jr. to Its Scientific Advisory Board

San Diego, California--(Newsfile Corp. - November 27, 2023) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) ("Thiogenesis" or the "Company") a clinical-stage biotechnology company developing sulfur-containing therapeutics for unmet pediatric diseases, today announced the addition of Vincent Stanton Jr., MD to its Scientific Advisory Board ("SAB"). Dr. Stanton was a co-founder of Thiogenesis Therapeutics, Inc., dating back to February 2016.Dr. Vincent Stanton Jr., MD is an entrepreneur and consulta

Related Keywords

Canada ,San Diego ,California ,United States ,Canadian ,Vincent Stanton Jr ,Company Filing Statement ,Dana Farber Cancer Institute ,Venture Exchange ,California Newsfile Corp ,Thiogenesis Therapeutics Inc ,Research At Variagenics ,Scientific Advisory Board ,Thiogenesis Therapeutics ,Senior Vice President ,Brook Riggins ,Thiogenesi Chief Financial Officer ,Lock Up Agreement ,Filing Statement ,Mitochondrial Encephalopathy Lactic Acidosis ,Incent Stanton Jr ,The Company ,Nc ,Stanton ,Pediatric Diseases ,Company ,